ECSP034635A - Uso de compuestos del 1-fenil-3-dimetilaminopropano para el tratamiento de la incontinencia urinaria - Google Patents

Uso de compuestos del 1-fenil-3-dimetilaminopropano para el tratamiento de la incontinencia urinaria

Info

Publication number
ECSP034635A
ECSP034635A EC2003004635A ECSP034635A ECSP034635A EC SP034635 A ECSP034635 A EC SP034635A EC 2003004635 A EC2003004635 A EC 2003004635A EC SP034635 A ECSP034635 A EC SP034635A EC SP034635 A ECSP034635 A EC SP034635A
Authority
EC
Ecuador
Prior art keywords
urinary incontinence
phenyl
treatment
dimethylamopropane
compounds
Prior art date
Application number
EC2003004635A
Other languages
English (en)
Inventor
Thomas Christoph
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of ECSP034635A publication Critical patent/ECSP034635A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención se relaciona con el uso de 1-fenil-3 dimetilaminopropano para la producción de un medicamento para el tratamiento del impulso aumentado de orinar o incontinencia urinaria, así como los medicamentos y métodos correspondientes para tratar el impulso aumentado de orinar o la incontinencia urinaria.
EC2003004635A 2000-11-30 2003-05-30 Uso de compuestos del 1-fenil-3-dimetilaminopropano para el tratamiento de la incontinencia urinaria ECSP034635A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10059412A DE10059412A1 (de) 2000-11-30 2000-11-30 Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz

Publications (1)

Publication Number Publication Date
ECSP034635A true ECSP034635A (es) 2003-07-25

Family

ID=7665210

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004635A ECSP034635A (es) 2000-11-30 2003-05-30 Uso de compuestos del 1-fenil-3-dimetilaminopropano para el tratamiento de la incontinencia urinaria

Country Status (28)

Country Link
US (1) US6841575B2 (es)
EP (1) EP1438034B1 (es)
JP (1) JP4284066B2 (es)
KR (1) KR100853364B1 (es)
CN (1) CN100421654C (es)
AT (1) ATE402694T1 (es)
AU (2) AU2002233210B2 (es)
BR (1) BR0115882A (es)
CA (1) CA2430332C (es)
CY (1) CY1108377T1 (es)
CZ (1) CZ20031508A3 (es)
DE (2) DE10059412A1 (es)
DK (1) DK1438034T3 (es)
EC (1) ECSP034635A (es)
ES (1) ES2311030T3 (es)
HU (1) HU228827B1 (es)
IL (2) IL156170A0 (es)
MX (1) MXPA03004712A (es)
NO (1) NO334109B1 (es)
NZ (1) NZ526603A (es)
PL (1) PL205081B1 (es)
PT (1) PT1438034E (es)
RU (1) RU2286768C2 (es)
SI (1) SI1438034T1 (es)
SK (1) SK287420B6 (es)
UA (1) UA74608C2 (es)
WO (1) WO2002043715A2 (es)
ZA (1) ZA200305006B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10109763A1 (de) * 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
US20050176790A1 (en) 2001-02-28 2005-08-11 Johannes Bartholomaus Pharmaceutical salts
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
US7410965B2 (en) 2002-05-29 2008-08-12 Gruenenthal Gmbh Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol
DE10224108A1 (de) * 2002-05-29 2004-01-29 Grünenthal GmbH 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung
DE10224624A1 (de) * 2002-05-30 2003-12-11 Gruenenthal Gmbh Metabolite und Prodrugs von 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol
DE10224556A1 (de) * 2002-05-31 2004-01-08 Grünenthal GmbH 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen
DE10225315A1 (de) * 2002-06-06 2003-12-24 Gruenenthal Gmbh Wirkstoffsalze und Ester von 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl- pentan-3-ol und 3-(3-Dimethylamino-1-ethyl-1-hydroxy-2-methyl- propyl)-phenol
ATE465726T1 (de) 2002-11-22 2010-05-15 Gruenenthal Gmbh Verwendung von (1r, 2r)-3-(3-dimenthylamino-1- ethyl-2-methyl-propyl)-phenol zur behandlung von entzündungsschmerz
GB2463151A (en) * 2008-09-05 2010-03-10 Acucela Inc Amine derivative compounds for treating ophthalmic diseases and disorders
WO2013016840A1 (zh) 2011-07-29 2013-02-07 安徽省新星药物开发有限责任公司 用于合成他喷他多或其类似物的新中间体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1213219B (it) * 1984-09-28 1989-12-14 Consiglio Nazionale Ricerche Derivati amminoalchilnaftalenici ad attivita' farmacologica.
SE9202218D0 (sv) * 1992-07-22 1992-07-22 Kabi Pharmacia Ab Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US5561154A (en) * 1994-07-27 1996-10-01 Institut De Recherches Chimiques Et Bioloques Appliquees Irceba Treatment of acute urinary retention
JP4085433B2 (ja) * 1997-04-11 2008-05-14 日本新薬株式会社 頻尿・尿失禁治療剤
DE19933421A1 (de) * 1999-07-16 2001-01-25 Gruenenthal Gmbh 2-Benzyl-3-dimethylamino-1-phenyl-propanderi- vate

Also Published As

Publication number Publication date
CN1622803A (zh) 2005-06-01
UA74608C2 (uk) 2006-01-16
HUP0302430A2 (hu) 2003-10-28
HU228827B1 (hu) 2013-05-28
SK287420B6 (sk) 2010-09-07
SI1438034T1 (sl) 2008-12-31
CA2430332C (en) 2011-03-15
ATE402694T1 (de) 2008-08-15
AU2002233210B2 (en) 2006-05-11
JP2004538246A (ja) 2004-12-24
DE10059412A1 (de) 2002-06-13
DE50114181D1 (de) 2008-09-11
DK1438034T3 (da) 2008-12-01
MXPA03004712A (es) 2003-08-19
BR0115882A (pt) 2003-12-02
IL156170A (en) 2007-02-11
HUP0302430A3 (en) 2009-08-28
JP4284066B2 (ja) 2009-06-24
ES2311030T3 (es) 2009-02-01
PL205081B1 (pl) 2010-03-31
CN100421654C (zh) 2008-10-01
KR20030059294A (ko) 2003-07-07
KR100853364B1 (ko) 2008-08-22
WO2002043715A2 (de) 2002-06-06
SK6632003A3 (en) 2004-08-03
PL366051A1 (en) 2005-01-24
EP1438034A2 (de) 2004-07-21
US6841575B2 (en) 2005-01-11
US20040034105A1 (en) 2004-02-19
ZA200305006B (en) 2007-11-28
NO334109B1 (no) 2013-12-09
NO20032406L (no) 2003-05-27
RU2286768C2 (ru) 2006-11-10
EP1438034B1 (de) 2008-07-30
CA2430332A1 (en) 2002-06-06
CZ20031508A3 (cs) 2003-10-15
NZ526603A (en) 2005-10-28
WO2002043715A3 (de) 2004-04-15
NO20032406D0 (no) 2003-05-27
HK1068274A1 (zh) 2005-04-29
IL156170A0 (en) 2003-12-23
AU3321002A (en) 2002-06-11
PT1438034E (pt) 2008-08-22
CY1108377T1 (el) 2014-02-12

Similar Documents

Publication Publication Date Title
SV2004001291A (es) Alquinos como inhibidores de metaloproteinasa de matriz ref. pc20536
CO4340688A1 (es) Derivados de quinazolina y procedimientos de uso de los mismos, como agentes contra el cancer, en los mamiferos.
ATE349976T1 (de) Mikrostruktur-stentstruktur
ATE461217T1 (de) Glp-1-verbindungen
CY1108377T1 (el) Χρηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια της ακρατειας ουρων
EA200400481A1 (ru) Применение флибансерина для лечения половых расстройств
AR028959A1 (es) Uso de rapamicina para la manufactura de un medicamento para tratar enfermedades cardiovasculares
BR0109163A (pt) Uso de pirido[3,2-e]-pirazinonas como inibidores da fosfodieterase 5, para terapia de disfunção erétil
AR040130A1 (es) Esteres de etonogestrel, su uso como anticopceptivo y para el tratamiento de desordenes ginecologicos
BRPI0409359A (pt) análogos quiméricos de somatostatina-dopamina
BRPI0409681A (pt) derivados de wortmanina solúveis em água
UY27451A1 (es) 2,5-diamidoindoles sustituidos y su utilización
SV2006002290A (es) Nonadepsipeptidos acilados ii ref. bhc041327-sv
UY26265A1 (es) Compuestos calciolíticos
ECSP034632A (es) Uso de compuestos del 6-dimetilaminometil-1-fenil-ciclohexaco sustituido en la terapia de la incontinencia urinaria
ECSP034636A (es) Uso de 6-dimetilaminometil-1-fenil-ciclohexaco sustituido en la terapia de la incontinencia urinaria
SV2002000355A (es) Aril- y heteroarilsulfonatos ref. lea 34321-sv
BRPI0414701A (pt) uso de um composto de vitamina d, método de prevenção ou tratamnento de disfunção de bexiga em um paciente, composto de vitamina d, e, kit
DK1368023T3 (da) Anvendelse af buprenoprphin til behandling af urininkontinens
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
AR030750A1 (es) 1-amino-alquilciclohexanos como agentes tripanocidas
CY1105814T1 (el) Δαριφενακινη για χρηση στη θεραπεια της επειξης προς ουρηση λογω υπepλειτουργικης ουροδοχου κυστης
BR0007395B1 (pt) compostos de s-nitrosotióis como agentes para o tratamento de disfunções circulatórias.
ES1047068Y (es) Juego de cuerpos lastrados para el tratamiento de la incontinencia urinaria.
CR8045A (es) Derivados de alcanos aza espiro como inhibidores de las metaloproteasas